Magdalena Jonikas

Magdalena is a Partner of Syncona Investment Management Limited.

She has led the foundation and build of several Syncona portfolio companies, including OMass Tx, Kesmalea Tx and Mosaic Tx, and currently serves as board Director for all three. She also previously served as interim CEO of Kesmalea Tx and Mosaic Tx.

Previously, Magdalena was an Associate Partner at McKinsey & Company where she advised global pharmaceutical companies on portfolio management and strategic topics across the therapeutics value chain. Before McKinsey, she was a postdoctoral fellow in Harvard Medical School's Computational Health Informatics Programme. Magdalena holds a PhD in Bioengineering from Stanford University and an undergraduate degree from the University of Pennsylvania.

Syncona portfolio companies

• OMass Therapeutics (Board member)
• Kesmalea Therapeutics (Board member)
• Mosaic Therapeutics (Board member)